Eugenics—once the discredited pseudoscience of forced sterilizations and racist categorizations—has not vanished. It has evolved. Not into overt ideology, but into algorithms, predictive models, and risk scores embedded in healthcare, insurance, and even employment screening.

Understanding the Context

The revival isn’t accidental. It’s engineered: by data-driven systems that conflate genetic predisposition with deterministic fate, often under the guise of “personalized prevention.” But beneath the veneer of precision lies a complex web of ethical ambiguities, technical fallacies, and systemic risks that demand rigorous scrutiny.

Why the old eugenics playbook no longer fits—yet echoes persist.

Traditional eugenics sought to “improve” populations through coercion and exclusion. Today’s eugenics operates through consent—albeit often coerced by social pressure or algorithmic nudges. Testing strategies now claim to empower individuals with genomic insights, but in doing so, they risk reinforcing hierarchies under the cover of science.

Recommended for you

Key Insights

The danger lies not in the data itself, but in how it’s interpreted, applied, and weaponized. A single polygenic risk score for Alzheimer’s, for instance, may not determine destiny—but it can dictate insurance premiums, employment eligibility, or even life insurance underwriting in ways that mirror historical discrimination.

Real-world examples reveal a troubling pattern. In 2021, a major U.S. health insurer deployed a polygenic risk assessment tool to identify individuals with elevated genetic risk for cardiovascular disease. The tool flagged thousands—many of whom were from marginalized communities already burdened by structural health disparities.

Final Thoughts

The intention was early intervention; the outcome deepened inequity. Risk scores, stripped of context, became proxies for social risk, amplifying existing biases rather than mitigating them.

Mechanics of Risk: The Hidden Mathematics

At the core of these testing strategies are polygenic risk scores (PRS), derived from genome-wide association studies (GWAS). These scores aggregate thousands of genetic variants, each contributing a tiny effect, to estimate an individual’s genetic predisposition to a condition. But PRS are not universal. They are built on datasets overwhelmingly composed of individuals of European ancestry, leading to skewed accuracy across populations. A test calibrated on one group often misclassifies risk in another—resulting in both false reassurances and unwarranted alarms.

This bias isn’t just statistical.

It reflects a deeper epistemological flaw: the conflation of statistical probability with causal certainty. A 30% higher PRS for breast cancer doesn’t mean a 30% chance of developing the disease. Yet, without nuanced communication, such metrics become deterministic judgments—verdicts that shape lives without considering environment, lifestyle, or social determinants. The test result becomes a label, not a guide.

Regulatory gaps and the illusion of scientific neutrality

Regulatory frameworks lag behind technological capability.